Callan Capital’s Neumora Therapeutics NMRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	$639K	Buy	638,784 +2,590	+0.4%	+$2.59K	0.05%	171
2024 Q4	$6.74M	Sell	636,194 -25,000	-4%	-$265K	0.49%	41
2024 Q3	$8.73M	Hold	661,194	–	–	0.61%	30
2024 Q2	$6.5M	Buy	661,194 +456,207	+223%	+$4.48M	0.53%	37
2024 Q1	$2.82M	Buy	+204,987	New	+$2.82M	0.25%	56